Aequus Pharmaceuticals Inc. filed its Annual on Jun 30, 2022 for the period ending Dec 31, 2021. In this report its auditor, Dale Matheson Carr-Hilton, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.02 CAD | -20.00% | 0.00% | -20.00% |
1st Jan change | Capi. | |
---|---|---|
-20.00% | 1.95M | |
+32.09% | 693B | |
+29.39% | 584B | |
-1.34% | 372B | |
+20.34% | 332B | |
+7.39% | 294B | |
+14.25% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+8.49% | 168B |
- Stock Market
- Equities
- AQS Stock
- News Aequus Pharmaceuticals Inc.
- Aequus Pharmaceuticals Inc. Auditor Raises 'Going Concern' Doubt